Strong platform, Expanding horizons

Building a platform that turns scale and strong brands into compounding value for shareholders.

Strong platform, Expanding horizons

Building a platform that turns scale and strong brands into compounding value for shareholders.

Optional Title

We deliver superior, sustainable value for our investors through a scalable platform, trusted brands, value-accretive M&A, diversified revenue streams, and resilient cash generation.

Vertically integrated and brand-led

With UK-based manufacturing, exclusive product licensing, and ownership of leading brands, Supreme benefits from complete control over quality, cost, and margin, generating the majority of profits from products we either own or produce in-house.

Efficient, scalable platform

Our centralised operating model leverages shared overheads and cross-category expertise, enabling scalable growth without proportional cost increases.

Privileged market access

Our long-standing relationships provide us with privileged access to a broad and expanding customer base, spanning major UK retailers, discounters, supermarkets, the public sector, and a growing direct-to consumer presence.

Financial strength and consistency

Delivered a 17% compound annual growth rate in both revenue and EBITDA from FY20 to FY25 whilst remaining capex-light and highly cash generative.

High calibre leadership

Our seasoned executive team brings deep sector expertise, supported by a PLC board with proven strategic and operational track records.

Disciplined, value-accretive M&A

We have a strong track record of acquiring businesses at attractive valuations and rapidly unlocking value through integration, delivering high returns on capital employed.

Customer-centric and disruption-driven

Through scaled UK manufacturing, global supplier networks, and relentless cost discipline, we offer high-quality, branded products at disruptively low prices; positioning ourselves as a supplier of choice in value-driven markets.

Diversified and resilient portfolio

Our broad product range benefits from multiple independent macro tailwinds. Coupled with a diverse customer mix including high-volume discounters, institutional buyers, and online platforms, this ensures resilience and multiple growth levers.

Financial Calendar

The provisional financial calendar is shown below:

Full Year Trading Update Typically due in April
Final Results Due in July
Annual Report published Due in August
Annual General Meeting Typically scheduled for September
Half-year Trading Update Typically due October
Interim Results Due in December

Regulatory Announcements

The latest Supreme research articles and publications provided by Equity Development.

Email Alert Services

Financial Reports

Date Report Download
2025 2025 Interim Results RNS
2025 2025 Annual General Meeting Proxy Card
2025 Notice of the 2025 Annual General Meeting
2025 Annual Report & Accounts for the year ended 31 March 2025
2024 2024 Interim Results RNS
2024 2024 Annual General Meeting Proxy Card
2024 Notice of the 2024 Annual General Meeting
2024 Annual Report & Accounts for the year ended 31 March 2024
2023 2023 Interim Results RNS
2023 2023 Annual General Meeting Proxy Card
2023 Notice of the 2023 Annual General Meeting
2023 Annual Report & Accounts for the year ended 31 March 2023
2022 2022 Interim Results RNS
2022 2022 Annual General Meeting Proxy Card
2022 Notice of the 2022 Annual General Meeting
2022 Annual Report & Accounts for the year ended 31 March 2022
2021 2021 Annual General Meeting Proxy Card
2021 Notice of the 2021 Annual General Meeting
2021 Annual Report & Accounts for the year ended 31 March 2021

Circulars

Date Report Download
2025 2025 Annual General Meeting Proxy Card
2025 Notice of the 2025 Annual General Meeting
2024 2024 Annual General Meeting Proxy Card
2024 Notice of the 2024 Annual General Meeting
2023 2023 Annual General Meeting Proxy Card
2023 Notice of the 2023 Annual General Meeting
2022 2022 Annual General Meeting Proxy Card
2022 Notice of the 2022 Annual General Meeting
2021 2021 Annual General Meeting Proxy Card
2021 Notice of the 2021 Annual General Meeting

Investor Presentation

27 November 2025 | Equity Development

Supreme – HY Results – Investor Presentation video – 25 November 2025

Sandy Chadha (CEO) and Suzanne Smith (CFO) of Supreme conducted an Investor Presentation covering Interim Results for the six months to 30th September 2025. Highlights included revenues +17% in the period, driven by acquisitions and organic growth. Management discussed how acquisitions continue to accelerate the Group’s ongoing product diversification strategy, the successful transition from disposable vapes to pod systems, and highlighted the Interim dividend of 1.6 pence. The team ran through the performance of each business division, and provided a detailed summary of Financials, before answering a wide range of questions submitted by the audience.

Investor Presentation

Sandy Chadha (CEO) and Suzanne Smith (CFO) of Supreme conducted an Investor Presentation covering Interim Results for the six months to 30th September 2025. Highlights included revenues +17% in the period, driven by acquisitions and organic growth. Management discussed how acquisitions continue to accelerate the Group’s ongoing product diversification strategy, the successful transition from disposable vapes to pod systems, and highlighted the Interim dividend of 1.6 pence. The team ran through the performance of each business division, and provided a detailed summary of Financials, before answering a wide range of questions submitted by the audience.

Presentations

Date Presentation Download
7th July 2026 Year End to 31st March 2026 Presentation
27th November 2025 Half Year End to 30th September 2025 Presentation

Share Price Information

Register for our email alert service to keep up to date with all of Supreme’s regulatory news announcements.

Analyst Research

View our latest Regulatory News announcements and sign up for email alerts whenever we release news updates

Date Presentation Download
7th July 2026 Equity Development – FY26 a record year and solid foundation for growth
1st July 2025 Equity Development – FY25 another strong year and platform for growth
23rd April 2025 Equity Development – Strong trading shows benefit of diversified portfolio
2nd July 2024 Equity Development – Supreme end of year results FY24
24th June 2024 Equity Development – Acquisition of Clearly Drinks
24th April 2024 Equity Development – Trading update highlights scale of growth
30th January 2024 Equity Development – Trading update: an excellent quarter
5th January 2024 Equity Development – Acquisition of protein manufacturing assets
28th November 2023 Equity Development – Striong H1 results raise full year outlook
18th October 2023 Equity Development – Positive trading update and vaping safety measures
26th September 2023 Equity Development – AGM update – FY24 significantly ahead
14th August 2023 Equity Development – Supreme end of year results FY23
12th April 2022 Equity Development – Research Note
7th December 2021 Equity Development – Supreme interim results 071221
5th July 2022 Equity Development – Supreme end of year results FY22
29h November 2022 Equity Development – Supreme interim results 291122

Investor Contacts & Advisers

For queries relating to financial publication relations or investor relations matters, please contact supreme@vigoconsulting.com

Company Secretary

Kevin Curry

Registered Office
4 Beacon Road
Trafford Park
Manchester M17 1AF

Nominated Adviser and Joint Broker

Shore Capital,
Cassini House,
57 St James’s Street,
London,
SW1A 1LD

Joint Broker

Zeus Capital Limited
82 King Street
Manchester
M2 4WQ

Registrar

Equiniti, Aspect House
Spencer Road,
Lancing Business Park,
West Sussex
BN99 6DA

Legal Advisers

Mills & Reeve LLP
Botanic House
100 Hills Road
Cambridge
CB2 1PH

Auditor

BDO LLP
3 Hardman Street,
Spinningfields
Manchester
M3 3AT

Financial Public Relations

Vigo Consulting
78-79 New Bond Street
London
W1S 1RZ